4//SEC Filing
Vanda Pharmaceuticals Inc. 4
Accession 0001209191-15-025769
$VNDACIK 0001347178operating
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 6:52 PM ET
Size
13.8 KB
Accession
0001209191-15-025769
Insider Transaction Report
Form 4
Baroldi Paolo
SVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2015-03-10+12,500→ 34,485 total - Exercise/Conversion
Common Stock
2015-03-10+5,000→ 39,485 total - Sale
Common Stock
2015-03-10$10.54/sh−8,940$94,228→ 30,545 total - Exercise/Conversion
Restricted Stock Unit
2015-03-10−5,000→ 15,000 total→ Common Stock (5,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2015-03-10−12,500→ 25,000 total→ Common Stock (12,500 underlying)
Footnotes (6)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
- [F2]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs as reflected in this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.46 to $10.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]The RSUs shall vest in four (4) equal annual installments beginning January 1, 2014, provided Reporting Person has remained in continuous service with the Issuer on each applicable vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F5]Not Applicable.
- [F6]The RSUs shall vest in four (4) equal annual installments beginning January 1, 2015, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001347178
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 6:52 PM ET
- Size
- 13.8 KB